[Clinical immunological effect of interferon in cases of influenza].
New drug formulation--a sublingual tablet--was developed on the basis of human leukocyte interferon (HLI). Evaluation of antiviral and immunomodulatory effects of the new formulation of HLI in patients with influenza showed its efficacy. The drug shortened duration of intoxication and catarrhal syndrome, decreased rate of complications and restored interferon status. Obtained results showed that "Interferon tablets 4000 IU" can be used in complex treatment of patients with influenza.
Volkova
L V
LV
Vorob'eva
N N
NN
Bondarenko
A L
AL
Sedel'nikova
N A
NA
Okishev
M A
MA
D000286:Administration, Sublingual; D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005334:Fever / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D007370:Interferon Type I; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007962:Leukocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012426:Russia; D013607:Tablets / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
D000998:Antiviral Agents; D007370:Interferon Type I; D013607:Tablets; D007372:Interferons